Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2025 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2024 Net Income-$2.71M-$2.71MN/M vs Q1 2024 EPS Diluted-$0.59-$0.59no prior Q1 2024 on file Operating Income-$2,726,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,618,000N/M ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end